Anatara Lifesciences Ltd (AU:ANR) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Anatara Lifesciences Limited has announced a change in the director’s interests, with John Michailidis acquiring 359,640 performance rights following shareholder approval at their recent AGM. This update indicates potential strategic moves within the company that may interest investors watching director activities closely.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.